Boston, MA -- (SBWIRE) -- 10/25/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Advanced Cell Technology, Inc. (OTCMKTS:ACTC) Interpublic Group of Companies Inc (NYSE:IPG) Avanir Pharmaceuticals Inc (NASDAQ:AVNR) GTx, Inc. (NASDAQ:GTXI).
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) opened its shares at the price of $0.06 for the day. Its closing price was $0.0611 after losing -1.29% for the day. The company traded with the total volume of 8.03 million shares, while its average trading volume remained 6.52 million shares. The beta of ACTC stands at-2.52.
Will ACTC Get Buyers Even After The Recent Rally? Find Out Here
Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine.
Interpublic Group of Companies Inc (NYSE:IPG) percentage change surged3.31 % to close at $15.91 with the total traded volume of 17.05 million shares, and average volume of 5.39 million. The 52 week range of the stock remained $9.38 - $17.55, while its day lowest price was $15.28 and it hit its day highest price at $16.00.
Will IPG Continue To Move Higher? Find Out Here
The Interpublic Group of Companies, Inc. (Interpublic) is a global advertising and marketing services companies. Interpublic’s companies specialize in consumer advertising, digital marketing, communications planning and media buying, public relations and specialized communications disciplines.
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) started its trading session with the price of $4.75 and closed at $4.96 by scoring 5.08%. AVNR’s stocks traded with total volume of 3.82 million shares, while the average trading volume remained 3.10 million shares. The beta of AVNR stands at 1.65. Day range of the stock was $4.75 -$5.07.
Will AVNR Continue To Move Higher? Find Out Here
AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders.
GTx, Inc. (NASDAQ:GTXI) ended its day with the gain of 4.60% and closed at the price of $1.82 after opening at $1.96. Stock traded during its last trading session with the total volume of 1.59 million shares, as compared to its average volume of 1.08 million shares.
Will GTXI Continue To Move Higher? Find Out Here
GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)